| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.905 | 0.001 | 0.916 | Viral attachment inhibitor | 0.916 0.001 DBMET03183 | DBMET03183 | |
| 0.33 | 0.067 | 0.33 | Immunomodulator | |||
| 0.267 | 0.054 | 0.267 | Antimitotic | |||
| 0.265 | 0.095 | 0.449 | Nootropic | 0.449 0.028 DBMET03183 | DBMET03183 | |
| 0.231 | 0.065 | 0.231 | Anticonvulsant | |||
| 0.151 | 0.011 | 0.151 | Purinergic P2X2 antagonist | |||
| 0.139 | 0.066 | 0.271 | Phosphodiesterase inhibitor | 0.271 0.019 DBMET03183 | DBMET03183 | |
| 0.172 | 0.109 | 0.172 | Angiogenesis stimulant | |||
| 0.111 | 0.072 | 0.111 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.059 | 0.027 | 0.118 | Factor IXa inhibitor | 0.118 0.006 DBMET03183 | DBMET03183 | |
| 0.041 | 0.01 | 0.041 | Purinergic P2T antagonist | 0.019 0.017 DBMET03183 | ||
| 0.074 | 0.05 | 0.074 | Nav1.8 sodium channel blocker | |||
| 0.035 | 0.015 | 0.035 | Purinergic P2X agonist | |||
| 0.036 | 0.02 | 0.036 | Purinergic P2Y2 antagonist | |||
| 0.067 | 0.053 | 0.067 | HIV-1 integrase inhibitor | |||
| 0.045 | 0.036 | 0.045 | Benzodiazepine inverse agonist | |||
| 0.049 | 0.039 | 0.056 | Antiviral (Hepatitis D) | 0.056 0.027 DBMET03183 | DBMET03183 | |
| 0.033 | 0.025 | 0.033 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.058 | 0.05 | 0.058 | Purinergic P2 antagonist | |||
| 0.096 | 0.09 | 0.096 | DNA polymerase I inhibitor | |||
| 0.155 | 0.152 | 0.155 | Tumour necrosis factor alpha release inhibitor | |||
| 0.008 | 0.006 | 0.008 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.014 | 0.02 | 0.03 | Factor IX inhibitor | 0.03 0.006 DBMET03183 | DBMET03183 | |
| 0.034 | 0.045 | 0.111 | Phosphodiesterase 10A inhibitor | 0.111 0.009 DBMET03183 | DBMET03183 | |
| 0.034 | 0.045 | 0.111 | Phosphodiesterase X inhibitor | 0.111 0.009 DBMET03183 | DBMET03183 | |
| 0.084 | 0.1 | 0.29 | GABA receptor agonist | 0.29 0.007 DBMET03183 | DBMET03183 | |
| 0.095 | 0.15 | 0.146 | Neurotrophic factor | 0.146 0.063 DBMET03183 | DBMET03183 | |
| 0.038 | 0.224 | 0.067 | MAP kinase kinase 8 inhibitor | 0.067 0.049 DBMET03183 | DBMET03183 | |
| 0.025 | 0.229 | 0.061 | Transcription factor AP-1 inhibitor | 0.061 0.043 DBMET03183 | DBMET03183 | |
| 0.049 | 0.269 | 0.077 | MAP kinase 7 inhibitor | 0.077 0.056 DBMET03183 | DBMET03183 | |
| 0.024 | 0.29 | 0.072 | Glutamate (mGluR group I) antagonist | 0.072 0.046 DBMET03183 | DBMET03183 | |
| 0.015 | 0.306 | 0.071 | MAP kinase 10 inhibitor | 0.071 0.063 DBMET03183 | DBMET03183 | |
| 0.009 | 0.356 | 0.061 | GABA receptor antagonist | 0.061 0.031 DBMET03183 | DBMET03183 | |
| 0.021 | 0.392 | 0.126 | GABA A receptor agonist | 0.126 0.021 DBMET03183 | DBMET03183 | |
| 0.017 | 0.525 | 0.054 | Phosphodiesterase 1B inhibitor | 0.054 0.051 DBMET03183 | DBMET03183 | |
| 0.005 | 0.522 | 0.074 | GABA A receptor antagonist | 0.074 0.024 DBMET03183 | DBMET03183 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |